2022 annual financial data
Arcutis Biotherapeutics 2022 Net income growth
Direct answer
Net income growth was -51.27%.
Operating income was -301,627,000 USD and net income was -311,458,000 USD.
Operating cash flow was -257,715,000 USD.
Get free Arcutis Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,686,000 USD
- Operating income
- -301,627,000 USD
- Net income
- -311,458,000 USD
- Operating cash flow
- -257,715,000 USD